_id

6914877dccc777a4e85d9708

Ticker

OKYO

Name

OKYO Pharma Ltd ADR

Exchange

NASDAQ

Address

14/15 Conduit St, London, United Kingdom, W1S 2XJ

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://okyopharma.com

Description

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Last Close

2.16

Volume

91073

Current Price

2.06

Change

-4.629629629629633

Last Updated

2025-12-02T13:02:20.173Z

Image

data:image/webp;base64,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

Ipo Date

2022-05-17T00:00:00.000Z

Market Cap

89889520

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9804999999999999

Sentiment Sources

2

Rating

4

Target Price

10

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

-

Cost Of Revenue

1289

Gross Profit

-1289

Operating Expenses

4178728

Operating Income

-4180017

Interest Expense

119790

Pretax Income

-3872416

Net Income

-2026474

Eps

-0.0562584161407786

Dividends Per Share

-

Shares Outstanding

37610676

Income Tax Expense

-1845942

EBITDA

-3751338

Operating Margin

-

Total Other Income Expense Net

307601

Cash

1560902

Short Term Investments

-

Receivables

1889039

Inventories

-

Total Current Assets

3675301

Property Plant Equipment

2035

Total Assets

3677336

Payables

7899986

Short Term Debt

-

Long Term Debt

-

Total Liabilities

9226891

Equity

-5549555

Depreciation

1289

Change In Working Capital

638642

Cash From Operations

-1569596

Capital Expenditures

1203

Cash From Investing

-1208

Cash From Financing

2103934

Net Change In Cash

573703

PE

-

PB

-13.370960176086191

ROE

36.515972902331804

ROA

-55.10712102456778

FCF

-1570799

Fcf Percent

-

Piotroski FScore

1

Health Score

39

Deep Value Investing Score

0.5

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

2

Growth Investing Score

2

Momentum Investing Score

2

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

-

Quarters > 0 > income Statement > cost Of Revenue

1289

Quarters > 0 > income Statement > gross Profit

-1289

Quarters > 0 > income Statement > operating Expenses

4178728

Quarters > 0 > income Statement > operating Income

-4180017

Quarters > 0 > income Statement > interest Expense

119790

Quarters > 0 > income Statement > pretax Income

-3872416

Quarters > 0 > income Statement > net Income

-2026474

Quarters > 0 > income Statement > eps

-0.0562584161407786

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

36020815

Quarters > 0 > income Statement > income Tax Expense

-1845942

Quarters > 0 > income Statement > EBITDA

-3751338

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

307601

Quarters > 0 > balance Sheet > cash

1560902

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

1889039

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

3675301

Quarters > 0 > balance Sheet > property Plant Equipment

2035

Quarters > 0 > balance Sheet > total Assets

3677336

Quarters > 0 > balance Sheet > payables

7899986

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

9226891

Quarters > 0 > balance Sheet > equity

-5549555

Quarters > 0 > cash Flow > net Income

-2026474

Quarters > 0 > cash Flow > depreciation

1289

Quarters > 0 > cash Flow > change In Working Capital

638642

Quarters > 0 > cash Flow > cash From Operations

-1569596

Quarters > 0 > cash Flow > capital Expenditures

1203

Quarters > 0 > cash Flow > cash From Investing

-1208

Quarters > 0 > cash Flow > cash From Financing

2103934

Quarters > 0 > cash Flow > net Change In Cash

573703

Quarters > 0 > ratios > PE

-0.0562584161407786

Quarters > 0 > ratios > PB

-13.370960176086191

Quarters > 0 > ratios > ROE

36.515972902331804

Quarters > 0 > ratios > ROA

-55.10712102456778

Quarters > 0 > ratios > FCF

-1570799

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

39

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

-

Quarters > 1 > income Statement > cost Of Revenue

1289

Quarters > 1 > income Statement > gross Profit

-1289

Quarters > 1 > income Statement > operating Expenses

7185205

Quarters > 1 > income Statement > operating Income

-4180017

Quarters > 1 > income Statement > interest Expense

125263

Quarters > 1 > income Statement > pretax Income

-3872416

Quarters > 1 > income Statement > net Income

-2026474

Quarters > 1 > income Statement > eps

-0.05131839704442759

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

39488256

Quarters > 1 > income Statement > income Tax Expense

-1845942

Quarters > 1 > income Statement > EBITDA

-7082190

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

307601

Quarters > 1 > balance Sheet > cash

1560902

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

1889039

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

3675301

Quarters > 1 > balance Sheet > property Plant Equipment

2035

Quarters > 1 > balance Sheet > total Assets

3677336

Quarters > 1 > balance Sheet > payables

7899986

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

9226891

Quarters > 1 > balance Sheet > equity

-5549555

Quarters > 1 > cash Flow > net Income

-2027487

Quarters > 1 > cash Flow > depreciation

1289

Quarters > 1 > cash Flow > change In Working Capital

638655.53

Quarters > 1 > cash Flow > cash From Operations

-1570380

Quarters > 1 > cash Flow > capital Expenditures

1203

Quarters > 1 > cash Flow > cash From Investing

-1208

Quarters > 1 > cash Flow > cash From Financing

2104985

Quarters > 1 > cash Flow > net Change In Cash

573703

Quarters > 1 > ratios > PE

-0.05131839704442759

Quarters > 1 > ratios > PB

-14.658077514323221

Quarters > 1 > ratios > ROE

36.515972902331804

Quarters > 1 > ratios > ROA

-55.10712102456778

Quarters > 1 > ratios > FCF

-1571583

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

-

Quarters > 2 > income Statement > cost Of Revenue

1857

Quarters > 2 > income Statement > gross Profit

-1857

Quarters > 2 > income Statement > operating Expenses

19.18

Quarters > 2 > income Statement > operating Income

1669

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

2048

Quarters > 2 > income Statement > net Income

-1013

Quarters > 2 > income Statement > eps

-0.02231130101535141

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

45403

Quarters > 2 > income Statement > income Tax Expense

708

Quarters > 2 > income Statement > EBITDA

-1875

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

379

Quarters > 2 > balance Sheet > cash

1560902

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

3675301

Quarters > 2 > balance Sheet > property Plant Equipment

2035

Quarters > 2 > balance Sheet > total Assets

3677336

Quarters > 2 > balance Sheet > payables

7899986

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

9226891

Quarters > 2 > balance Sheet > equity

-5549555

Quarters > 2 > cash Flow > net Income

-1013

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

13.53

Quarters > 2 > cash Flow > cash From Operations

-784

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

1051

Quarters > 2 > cash Flow > net Change In Cash

-

Quarters > 2 > ratios > PE

-0.02231130101535141

Quarters > 2 > ratios > PB

-0.01685363601225684

Quarters > 2 > ratios > ROE

0.01825371583847714

Quarters > 2 > ratios > ROA

-0.027547115629357775

Quarters > 2 > ratios > FCF

-784

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

24

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

1274

Quarters > 3 > income Statement > gross Profit

-1274

Quarters > 3 > income Statement > operating Expenses

1107

Quarters > 3 > income Statement > operating Income

-3008858

Quarters > 3 > income Statement > interest Expense

758384

Quarters > 3 > income Statement > pretax Income

-4097655

Quarters > 3 > income Statement > net Income

-2679818

Quarters > 3 > income Statement > eps

-0.07982062967265362

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

33573000

Quarters > 3 > income Statement > income Tax Expense

-1417837

Quarters > 3 > income Statement > EBITDA

-1669

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-1088797

Quarters > 3 > balance Sheet > cash

987199

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

1515564

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

2826700

Quarters > 3 > balance Sheet > property Plant Equipment

2158

Quarters > 3 > balance Sheet > total Assets

2828858

Quarters > 3 > balance Sheet > payables

9607048

Quarters > 3 > balance Sheet > short Term Debt

1808

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

10054490

Quarters > 3 > balance Sheet > equity

-7225632

Quarters > 3 > cash Flow > net Income

-2678

Quarters > 3 > cash Flow > depreciation

1274

Quarters > 3 > cash Flow > change In Working Capital

-117.47

Quarters > 3 > cash Flow > cash From Operations

-241455

Quarters > 3 > cash Flow > capital Expenditures

5

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

552083.9

Quarters > 3 > cash Flow > net Change In Cash

279884

Quarters > 3 > ratios > PE

-0.07982062967265362

Quarters > 3 > ratios > PB

-9.57153367345583

Quarters > 3 > ratios > ROE

37.08766236641999

Quarters > 3 > ratios > ROA

-94.73144286492995

Quarters > 3 > ratios > FCF

-241460

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

39

Annuals > 0 > quarter

2025-03-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

2563

Annuals > 0 > income Statement > gross Profit

-2563

Annuals > 0 > income Statement > operating Expenses

7186312

Annuals > 0 > income Statement > operating Income

-7188875

Annuals > 0 > income Statement > interest Expense

883647

Annuals > 0 > income Statement > pretax Income

-7970071

Annuals > 0 > income Statement > net Income

-4706292

Annuals > 0 > income Statement > eps

-0.11918206770134392

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

39488256

Annuals > 0 > income Statement > income Tax Expense

-3263779

Annuals > 0 > income Statement > EBITDA

-7083859

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

-781196

Annuals > 0 > balance Sheet > cash

1560902

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

1889039

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

3675301

Annuals > 0 > balance Sheet > property Plant Equipment

2035

Annuals > 0 > balance Sheet > total Assets

3677336

Annuals > 0 > balance Sheet > payables

7899986

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

9226891

Annuals > 0 > balance Sheet > equity

-5549555

Annuals > 0 > cash Flow > net Income

-7970071

Annuals > 0 > cash Flow > depreciation

2563

Annuals > 0 > cash Flow > change In Working Capital

3625008

Annuals > 0 > cash Flow > cash From Operations

-1810931

Annuals > 0 > cash Flow > capital Expenditures

1208

Annuals > 0 > cash Flow > cash From Investing

-1208

Annuals > 0 > cash Flow > cash From Financing

2655742

Annuals > 0 > cash Flow > net Change In Cash

734054

Annuals > 0 > ratios > PE

-0.11918206770134392

Annuals > 0 > ratios > PB

-13.234963192544267

Annuals > 0 > ratios > ROE

84.80485372250568

Annuals > 0 > ratios > ROA

-127.98101669251871

Annuals > 0 > ratios > FCF

-1812139

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

30

Annuals > 1 > quarter

2024-03-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

3866

Annuals > 1 > income Statement > gross Profit

-3866

Annuals > 1 > income Statement > operating Expenses

15690683

Annuals > 1 > income Statement > operating Income

-15694549

Annuals > 1 > income Statement > interest Expense

1053313

Annuals > 1 > income Statement > pretax Income

-16803045

Annuals > 1 > income Statement > net Income

-16825461

Annuals > 1 > income Statement > eps

-0.5734062979245476

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

29343000

Annuals > 1 > income Statement > income Tax Expense

22415

Annuals > 1 > income Statement > EBITDA

-15745863

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

-1108496

Annuals > 1 > balance Sheet > cash

826848

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

580940

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

1537914

Annuals > 1 > balance Sheet > property Plant Equipment

3350

Annuals > 1 > balance Sheet > total Assets

1541264

Annuals > 1 > balance Sheet > payables

6128132

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

7420846

Annuals > 1 > balance Sheet > equity

-5879582

Annuals > 1 > cash Flow > net Income

-16825461

Annuals > 1 > cash Flow > depreciation

3866

Annuals > 1 > cash Flow > change In Working Capital

2669464

Annuals > 1 > cash Flow > cash From Operations

-9490537

Annuals > 1 > cash Flow > capital Expenditures

3

Annuals > 1 > cash Flow > cash From Investing

-

Annuals > 1 > cash Flow > cash From Financing

6208508

Annuals > 1 > cash Flow > net Change In Cash

-3218533

Annuals > 1 > ratios > PE

-0.5734062979245476

Annuals > 1 > ratios > PB

-9.282629275346446

Annuals > 1 > ratios > ROE

286.16763912808767

Annuals > 1 > ratios > ROA

-1091.666385512151

Annuals > 1 > ratios > FCF

-9490540

Annuals > 1 > ratios > Piotroski FScore

1

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

31

Annuals > 2 > quarter

2023-03-31

Annuals > 2 > income Statement > revenue

0

Annuals > 2 > income Statement > cost Of Revenue

3797

Annuals > 2 > income Statement > gross Profit

-3797

Annuals > 2 > income Statement > operating Expenses

6337698

Annuals > 2 > income Statement > operating Income

-13087270

Annuals > 2 > income Statement > interest Expense

96687

Annuals > 2 > income Statement > pretax Income

-13284000

Annuals > 2 > income Statement > net Income

-13272000

Annuals > 2 > income Statement > eps

-0.596306779889473

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

22257000

Annuals > 2 > income Statement > income Tax Expense

-12202

Annuals > 2 > income Statement > EBITDA

-13183000

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

-196617

Annuals > 2 > balance Sheet > cash

4045381

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

980075

Annuals > 2 > balance Sheet > inventories

170314

Annuals > 2 > balance Sheet > total Current Assets

5196704

Annuals > 2 > balance Sheet > property Plant Equipment

7216

Annuals > 2 > balance Sheet > total Assets

5203920

Annuals > 2 > balance Sheet > payables

1023788

Annuals > 2 > balance Sheet > short Term Debt

2215111

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

7257157

Annuals > 2 > balance Sheet > equity

-2053237

Annuals > 2 > cash Flow > net Income

-13283887

Annuals > 2 > cash Flow > depreciation

3797

Annuals > 2 > cash Flow > change In Working Capital

4144949

Annuals > 2 > cash Flow > cash From Operations

-7695242

Annuals > 2 > cash Flow > capital Expenditures

5916

Annuals > 2 > cash Flow > cash From Investing

-5916

Annuals > 2 > cash Flow > cash From Financing

9323354

Annuals > 2 > cash Flow > net Change In Cash

1344657

Annuals > 2 > ratios > PE

-0.596306779889473

Annuals > 2 > ratios > PB

-20.16231930361668

Annuals > 2 > ratios > ROE

646.393962314141

Annuals > 2 > ratios > ROA

-255.03850943135174

Annuals > 2 > ratios > FCF

-7701158

Annuals > 2 > ratios > Piotroski FScore

1

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

31

Annuals > 3 > quarter

2022-03-31

Annuals > 3 > income Statement > revenue

0

Annuals > 3 > income Statement > cost Of Revenue

2423

Annuals > 3 > income Statement > gross Profit

-2423

Annuals > 3 > income Statement > operating Expenses

6218000

Annuals > 3 > income Statement > operating Income

-6231000

Annuals > 3 > income Statement > interest Expense

0

Annuals > 3 > income Statement > pretax Income

-6218000

Annuals > 3 > income Statement > net Income

-5431000

Annuals > 3 > income Statement > eps

-0.36052841210833775

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

15064000

Annuals > 3 > income Statement > income Tax Expense

-787000

Annuals > 3 > income Statement > EBITDA

-6215000

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

13577

Annuals > 3 > balance Sheet > cash

2700724

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

883435

Annuals > 3 > balance Sheet > inventories

-1491

Annuals > 3 > balance Sheet > total Current Assets

4295368

Annuals > 3 > balance Sheet > property Plant Equipment

5225

Annuals > 3 > balance Sheet > total Assets

4300593

Annuals > 3 > balance Sheet > payables

517667

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

1353191

Annuals > 3 > balance Sheet > equity

2947402

Annuals > 3 > cash Flow > net Income

-6217566

Annuals > 3 > cash Flow > depreciation

2331

Annuals > 3 > cash Flow > change In Working Capital

-1023869

Annuals > 3 > cash Flow > cash From Operations

-5468065

Annuals > 3 > cash Flow > capital Expenditures

1669

Annuals > 3 > cash Flow > cash From Investing

-1669

Annuals > 3 > cash Flow > cash From Financing

2153270

Annuals > 3 > cash Flow > net Change In Cash

-4188605

Annuals > 3 > ratios > PE

-0.36052841210833775

Annuals > 3 > ratios > PB

9.506351695493183

Annuals > 3 > ratios > ROE

-184.2639721354603

Annuals > 3 > ratios > ROA

-126.28491001124729

Annuals > 3 > ratios > FCF

-5469734

Annuals > 3 > ratios > Piotroski FScore

1

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

27

Valuation > metrics > PE

-0.0562584161407786

Valuation > metrics > PB

-13.370960176086191

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

36.515972902331804

Profitability > metrics > ROA

-55.13763362510989

Profitability > final Score

55

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-34.894540445780116

Risk > final Score

-110

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.46522879913964404

Liquidity > metrics > Quick Ratio

0.46522879913964404

Liquidity > final Score

33

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

55

Prev Profitabilities > 1

15

Prev Profitabilities > 2

55

Prev Risks > 0

-103

Prev Risks > 1

32

Prev Risks > 2

14

Prev Liquidities > 0

33

Prev Liquidities > 1

33

Prev Liquidities > 2

25

Updated At

2025-12-14T00:58:05.376Z

Earnings History > 0 > period

2026-06-30

Earnings History > 0 > report Date

2026-08-10

Earnings History > 0 > date

2026-06-30

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2025-12-31

Earnings History > 1 > report Date

2026-02-25

Earnings History > 1 > date

2025-12-31

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

-

Earnings History > 1 > eps Actual

0

Earnings History > 1 > eps Estimate

-0.04

Earnings History > 1 > eps Difference

0.04

Earnings History > 1 > surprise Percent

100

Earnings History > 2 > period

2025-09-30

Earnings History > 2 > report Date

2025-12-22

Earnings History > 2 > date

2025-09-30

Earnings History > 2 > before After Market

AfterMarket

Earnings History > 2 > currency

-

Earnings History > 2 > eps Actual

-

Earnings History > 2 > eps Estimate

-0.04

Earnings History > 2 > eps Difference

0

Earnings History > 2 > surprise Percent

-

Earnings History > 3 > period

2025-06-30

Earnings History > 3 > report Date

2025-08-05

Earnings History > 3 > date

2025-06-30

Earnings History > 3 > before After Market

-

Earnings History > 3 > currency

-

Earnings History > 3 > eps Actual

-0.06

Earnings History > 3 > eps Estimate

-0.05

Earnings History > 3 > eps Difference

-0.01

Earnings History > 3 > surprise Percent

-20

Earnings History > 4 > period

2025-03-31

Earnings History > 4 > report Date

2025-03-31

Earnings History > 4 > date

2025-03-31

Earnings History > 4 > before After Market

-

Earnings History > 4 > currency

-

Earnings History > 4 > eps Actual

-

Earnings History > 4 > eps Estimate

-0.05

Earnings History > 4 > eps Difference

0

Earnings History > 4 > surprise Percent

-

Earnings History > 5 > period

2024-12-31

Earnings History > 5 > report Date

2025-01-29

Earnings History > 5 > date

2024-12-31

Earnings History > 5 > before After Market

-

Earnings History > 5 > currency

-

Earnings History > 5 > eps Actual

-0.08

Earnings History > 5 > eps Estimate

-0.09

Earnings History > 5 > eps Difference

0.01

Earnings History > 5 > surprise Percent

11.1111

Earnings History > 6 > period

2024-09-30

Earnings History > 6 > report Date

2024-09-30

Earnings History > 6 > date

2024-09-30

Earnings History > 6 > before After Market

-

Earnings History > 6 > currency

-

Earnings History > 6 > eps Actual

-

Earnings History > 6 > eps Estimate

-0.09

Earnings History > 6 > eps Difference

0

Earnings History > 6 > surprise Percent

-

Earnings History > 7 > period

2024-06-30

Earnings History > 7 > report Date

2024-07-30

Earnings History > 7 > date

2024-06-30

Earnings History > 7 > before After Market

-

Earnings History > 7 > currency

-

Earnings History > 7 > eps Actual

-0.09

Earnings History > 7 > eps Estimate

-0.09

Earnings History > 7 > eps Difference

0

Earnings History > 7 > surprise Percent

0

Earnings History > 8 > period

2024-03-31

Earnings History > 8 > report Date

2024-03-31

Earnings History > 8 > date

2024-03-31

Earnings History > 8 > before After Market

-

Earnings History > 8 > currency

-

Earnings History > 8 > eps Actual

-

Earnings History > 8 > eps Estimate

-0.09

Earnings History > 8 > eps Difference

0

Earnings History > 8 > surprise Percent

-

Earnings History > 9 > period

2023-12-31

Earnings History > 9 > report Date

2024-01-09

Earnings History > 9 > date

2023-12-31

Earnings History > 9 > before After Market

AfterMarket

Earnings History > 9 > currency

USD

Earnings History > 9 > eps Actual

-0.1

Earnings History > 9 > eps Estimate

-0.1

Earnings History > 9 > eps Difference

0

Earnings History > 9 > surprise Percent

0

Earnings History > 10 > period

2023-09-30

Earnings History > 10 > report Date

2023-12-28

Earnings History > 10 > date

2023-09-30

Earnings History > 10 > before After Market

BeforeMarket

Earnings History > 10 > currency

USD

Earnings History > 10 > eps Actual

-0.11

Earnings History > 10 > eps Estimate

-0.11

Earnings History > 10 > eps Difference

0

Earnings History > 10 > surprise Percent

0

Earnings History > 11 > period

2023-06-30

Earnings History > 11 > report Date

2023-08-15

Earnings History > 11 > date

2023-06-30

Earnings History > 11 > before After Market

BeforeMarket

Earnings History > 11 > currency

USD

Earnings History > 11 > eps Actual

-0.34

Earnings History > 11 > eps Estimate

-0.11

Earnings History > 11 > eps Difference

-0.23

Earnings History > 11 > surprise Percent

-209.0909